2022 ESC/EACTS联合综述:低外科风险且解剖适合PCI或CABG的左主干病变血运重建指南推荐
结论认为对于解剖适合两种术式且预测外科死亡率低的稳定患者,CABG(I类,A级证据)和PCI(IIa类,A级证据)均临床合理,选择应基于患者偏好、术者专业能力和当地手术量。
要点
- 低外科风险、解剖适合PCI或CABG的左主干病变稳定患者,CABG推荐为I类A级,PCI为IIa类A级。
- 血运重建方式选择应基于患者偏好、术者专业能力和当地手术量。
- 四项随机试验汇总数据仅足以排除大的死亡率差异,存在重要知识缺口。
核心结论
- 对于低至中危SYNTAX评分(0-32)左主干病变、解剖适合PCI或CABG且预测外科死亡率低的稳定患者,CABG(I类,A级证据)和PCI(IIa类,A级证据)均临床合理。
- 治疗选择应基于患者偏好、术者专业能力和当地手术量。
研究设计与样本
- 工作组审查对象为低至中危SYNTAX评分(0-32)的左主干病变患者。
主要发现
- 四项随机试验的汇总数据仅足以排除大的死亡率差异。
- 工作组识别出左主干病变血运重建相关的多个重要知识缺口。
关键数值与推荐
- CABG推荐为I类,证据级别A。
- PCI推荐为IIa类,证据级别A。
临床怎么用
- 对符合条件(低至中危SYNTAX评分0-32、解剖适合两种术式、预测外科死亡率低)的稳定左主干病变患者,可根据患者偏好、术者专业能力和当地手术量选择CABG或PCI。
局限性
- 四项随机试验汇总数据仅足以排除大的死亡率差异。
- 工作组识别出左主干病变血运重建相关的多个重要知识缺口。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In October 2021, the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) jointly agreed to establish a Task Force (TF) to review recommendations of the 2018 ESC/EACTS Guidelines on myocardial revascularization as they apply to patients with left main (LM) disease with low-to-intermediate SYNTAX score (0-32). This followed the withdrawal of support by the EACTS in 2019 for the recommendations about the management of LM disease of the previous guideline. The TF was asked to review all new relevant data since the 2018 guidelines including updated aggregated data from the four randomized trials comparing percutaneous coronary intervention (PCI) with drug-eluting stents vs. coronary artery bypass grafting (CABG) in patients with LM disease. This document represents a summary of the work of the TF; suggested updated recommendations for the choice of revascularization modality in patients undergoing myocardial revascularization for LM disease are included. In stable patients with an indication for revascularization for LM disease, with coronary anatomy suitable for both procedures and a low predicted surgical mortality, the TF concludes that both treatment options are clinically reasonable based on patient preference, available expertise, and local operator volumes. The suggested recommendations for revascularization with CABG are Class I, Level of Evidence A. The recommendations for PCI are Class IIa, Level of Evidence A. The TF recognized several important gaps in knowledge related to revascularization in patients with LM disease and recognizes that aggregated data from the four randomized trials were still only large enough to exclude large differences in mortality.
引用
- Byrne RA, Fremes S, Capodanno D, et al. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. Eur Heart J. 2023. PMID: 37632756. doi:10.1093/eurheartj/ehad476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。